In the last years, many groups have deep investigated the role of defective HR mechanisms in cancer: the so-called “BRCAness” status is defined as the presence in tumor cells of alternative mechanisms impairing BRCA1/2 functions, or the alteration in HR genes. Here, BRCA1 is linked to neoplasm.